Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Intranasal Insulin for Alzheimer’s Disease
Manfred Hallschmid
CNS Drugs (2021) Vol. 35, Iss. 1, pp. 21-37
Open Access | Times Cited: 109

Showing 1-25 of 109 citing articles:

Metabolic Syndrome as a Risk Factor for Alzheimer’s Disease: A Focus on Insulin Resistance
Amaia Ezkurdia, Marı́a J. Ramı́rez, Maite Solas
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4354-4354
Open Access | Times Cited: 71
Phytochemicals targeting Alzheimer's disease via the AMP-activated protein kinase pathway, effects, and mechanisms of action
Zheng Zhao, Jun Yan, Lei Huang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116373-116373
Open Access | Times Cited: 15
Deciphering the Roles of Metformin in Alzheimer’s Disease: A Snapshot
Wang Liao, Jiaxin Xu, Bo Li, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 60
Targeting whole body metabolism and mitochondrial bioenergetics in the drug development for Alzheimer's disease
Steven N. Austad, Scott W. Ballinger, Thomas W. Buford, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 2, pp. 511-531
Open Access | Times Cited: 56
Targeting the overexpressed mitochondrial protein VDAC1 in a mouse model of Alzheimer’s disease protects against mitochondrial dysfunction and mitigates brain pathology
Ankit Verma, Anna Shteinfer‐Kuzmine, Nikita Kamenetsky, et al.
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 54
A Potential Link Between Visceral Obesity and Risk of Alzheimer’s Disease
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Abdulrahman A. Alsayegh, et al.
Neurochemical Research (2022) Vol. 48, Iss. 3, pp. 745-766
Closed Access | Times Cited: 53
Mechanisms underlying HIV-associated cognitive impairment and emerging therapies for its management
Ronald J. Ellis, María J. Marquine, Marcus Kaul, et al.
Nature Reviews Neurology (2023) Vol. 19, Iss. 11, pp. 668-687
Open Access | Times Cited: 29
Hot Spots for the Use of Intranasal Insulin: Cerebral Ischemia, Brain Injury, Diabetes Mellitus, Endocrine Disorders and Postoperative Delirium
А. О. Шпаков, И. И. Зорина, К. В. Деркач
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3278-3278
Open Access | Times Cited: 28
Protein aggregation: Consequences, mechanism, characterization and inhibitory strategies
Nabeela Majid, Rizwan Hasan Khan
International Journal of Biological Macromolecules (2023) Vol. 242, pp. 125123-125123
Closed Access | Times Cited: 24
Unraveling the intercellular communication disruption and key pathways in Alzheimer’s disease: an integrative study of single-nucleus transcriptomes and genetic association
Andi Liu, Brisa S. Fernandes, Citu Citu, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 14
Synthesis of a Rivastigmine and Insulin Combinational Mucoadhesive Nanoparticle for Intranasal Delivery
Tahereh Jamshidnejad-Tosaramandani, Soheila Kashanian, Isaac Karimi, et al.
Polymers (2024) Vol. 16, Iss. 4, pp. 510-510
Open Access | Times Cited: 12
Nasal tau immunotherapy clears intracellular tau pathology and improves cognitive functions in aged tauopathy mice
Sagar Gaikwad, Nicha Puangmalai, Minal Sonawane, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 754
Closed Access | Times Cited: 9
Recent Advances in Drug Delivery Systems Targeting Insulin Signalling for the Treatment of Alzheimer’s Disease
Punya Sachdeva, Kannan Badri Narayanan, Jitendra Kumar Sinha, et al.
Journal of Alzheimer s Disease (2024) Vol. 98, Iss. 4, pp. 1169-1179
Closed Access | Times Cited: 8
Liposome-Derived Nanosystems for the Treatment of Behavioral and Neurodegenerative Diseases: The Promise of Niosomes, Transfersomes, and Ethosomes for Increased Brain Drug Bioavailability
Patrícia C. Pires, Ana Cláudia Paiva‐Santos, Francisco Veiga
Pharmaceuticals (2023) Vol. 16, Iss. 10, pp. 1424-1424
Open Access | Times Cited: 19
Effect of the Lipid Landscape on the Efficacy of Cell-Penetrating Peptides
Florina Zákány, István M. Mándity, Zoltán Varga, et al.
Cells (2023) Vol. 12, Iss. 13, pp. 1700-1700
Open Access | Times Cited: 18
Integrated transcriptome and metabolome analysis to investigate the mechanism of intranasal insulin treatment in a rat model of vascular dementia
Liang Tang, Yan Wang, Xujing Gong, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 16
Alzheimer’s Disease Treatment: The Search for a Breakthrough
Allison B. Reiss, Dalia Muhieddine, Berlin Jacob, et al.
Medicina (2023) Vol. 59, Iss. 6, pp. 1084-1084
Open Access | Times Cited: 16
Triglyceride-glucose index predicts postoperative delirium in elderly patients with type 2 diabetes mellitus: a retrospective cohort study
Miao Sun, Min Liu, Faqiang Zhang, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 6
A Tale of Two Diseases: Exploring Mechanisms Linking Diabetes Mellitus with Alzheimer’s Disease
Jessica Lynn, Mingi Park, Christiana Ogunwale, et al.
Journal of Alzheimer s Disease (2021) Vol. 85, Iss. 2, pp. 485-501
Closed Access | Times Cited: 33
Metabolic Regulation of Mitochondrial Protein Biogenesis from a Neuronal Perspective
J. Tabitha Hees, Angelika B. Harbauer
Biomolecules (2022) Vol. 12, Iss. 11, pp. 1595-1595
Open Access | Times Cited: 25
Brain insulin responsiveness is linked to age and peripheral insulin sensitivity
Lore Wagner, Ralf Veit, Christian Kübler, et al.
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 8, pp. 2171-2180
Open Access | Times Cited: 14
Evidence of disturbed insulin signaling in animal models of Alzheimer’s disease
Suélen Santos Alves, Gabriel Servilha‐Menezes, Letícia Rossi, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 152, pp. 105326-105326
Closed Access | Times Cited: 14
Intranasal Insulin Administration Affecting Perioperative Neurocognitive Dysfunction by Regulating Calcium Transport Protein Complex IP3R/GRP75/VDAC1 on MAMs
Huiqin Liu, Yanhua Jiang, Cong Lin, et al.
Free Radical Biology and Medicine (2025) Vol. 228, pp. 240-250
Closed Access
Nose-to-brain delivery of DHA-loaded nanoemulsions: A promising approach against Alzheimer’s disease
Léa Otaegui, Théo Urgin, Taghrid Zaiter, et al.
International Journal of Pharmaceutics (2025) Vol. 670, pp. 125125-125125
Open Access
Intranasal Insulin Diminishes Postoperative Delirium and Elevated Osteocalcin and Brain Derived Neurotrophic Factor in Older Patients Undergoing Joint Replacement: A Randomized, Double-Blind, Placebo-Controlled Trial
Yang Mi, Lei Zhou, Ge Long, et al.
Drug Design Development and Therapy (2025) Vol. Volume 19, pp. 759-769
Open Access
Page 1 - Next Page

Scroll to top